WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 63.90
+0.20 (0.31%)
Jul 18, 2025, 11:52 AM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 2.91 billion as of July 18, 2025. Its market cap has decreased by -2.93% in one year.
Market Cap
2.91B
Enterprise Value
3.24B
Revenue
1.00B
Ranking
n/a
PE Ratio
16.14
Stock Price
63.90
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 2.91B, a decrease of -15.28%. That is a compound annual growth rate of -10.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 2.91B | -10.39% |
| Dec 31, 2024 | 3.24B | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 188.45B |
| PharmaEssentia | 182.63B |
| Bora Pharmaceuticals Co., LTD. | 85.85B |
| Lotus Pharmaceutical | 56.80B |
| Oneness Biotech | 29.27B |
| Polaris Group | 28.81B |
| Center Laboratories | 26.28B |
| Lumosa Therapeutics | 24.48B |